Yıl: 2020 Cilt: 26 Sayı: 2 Sayfa Aralığı: 138 - 142 Metin Dili: İngilizce DOI: DOI: 10.5152/EurJTher.2019.18063 İndeks Tarihi: 20-11-2020

HLA-G with Benefits and Damages: A Review

Öz:
Human leucocyte antigen-G (HLA-G) is a non-classical HLA that researchers primarily focused on association with the complications of pregnancy. Recent studies about the immunomodulatory characteristics of HLA-G showed that this molecule is not only important in pregnancy but also have effects on transplantation, autoimmune diseases, cancer and infectious diseases. The restricted polymorphic nature and the disease association has also showed in various studies. In this review it was aimed to evaluate the benefits and damages of the HLA-G by considering both the expression levels and polymorphisms.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • Gürbüz BÇ, Soyöz M, Ayna TK, Pirim İ. Importance of Pregnancy Induced Paternal HLA Antibody Production in Transplantation: Review. Turkiye Klinikleri J Med Sci 2016; 36(2): 106.
  • Misra MK, Pandey S K, Kapoor R, Sharma RK, KapoorR, Prakash S et al. HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection. Hum Immunol 2014; 75(8): 833.
  • Amiot L, Vu N, Samson M. Biology of the immunomodulatory molecule HLA-G in human liver diseases. J Hepatol 2015; 62(6): 1430.
  • Porto IOP, Junior-Mendes CT, Felicio LP, Georg RC, Moreau P, Donadi EA. MicroRNAs targeting the immunomodulatory HLA-G gene: A new survey searching for microRNAs with potential to regulate HLA-G. Mol Immunol. 2015; 65: 230.
  • Poláková K, Bandžuchová H, Žilinská Z, Chreňová S, Kuba D, Russ G. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients. Immunobiology 2015; 220(4): 533.
  • Lazarte J, Tumiati LC, Rao V, Delgado DH. New Developments in HLA-G in Cardiac Transplantation. Hum Immunol 2016; 77(9): 740.
  • Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008; 29(7): 313.
  • Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT. Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans. Infect Genet Evol 2015; 30: 147.
  • Zidi I, Rizzo R, Bouaziz A, Laaribi AB, Zidi N, Luca DD et al. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion. Hum Immunol 2016; 77: 342.
  • 10. Zidi I, Amor NB. HLA-G as predisposing for metastasis. Med hypotheses 2011; 77(1): 134.
  • 11. Christiansen OB, Kolte AM, Dahl M, Larsen EC, Steffensen R, Nielsen HS et al. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-g gene and carriage of HLA class ii alleles restricting immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients. Hum Immunol 2012; 73: 699.
  • 12. Dahl M, Klitkou L, Christiansen OB, Djurisic S, Piosik ZM, Skovbo P et al. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G. Hum Immunol 2015; 76(4): 260.
  • 13. Seliger B. Role of microRNAs on HLA-G expression in human tumors. Hum Immunol 2016; 77(9): 760.
  • 14. Wu CL, Svendsen SG, Riviere A, Desgrandchamps F, Carosella ED, LeMaoult J. Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4. Hum Immunol 2016; 77(9): 720.
  • 15. Favier B, Lemaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010; 24: 689.
  • 16. Rebmann V, Wagner S, Grosse-Wilde H. HLA-G expression in malignant melanoma. Semin in cancer bio 2007; 17(6): 422.
  • 17. Guerini FR, Bolognesi E, Chiappedi M, Ghezzo A, Canevini MP, Mensi MM et al. An HLA-G∗ 14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders. Brain Behav Immun 2015; 44: 207.
  • 18. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220.
  • 19. Zhang X, Han QY, Li JB, Ruan YY, Yan WH, Lin A. Lesion HLA-G5/-G6 isoforms expression in patients with ovarian cancer. Hum Immunol 2016; 77(9): 780.
  • 20. Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction 2006; 131(3): 583.
  • 21. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004; 191(2): 525.
  • 22. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A et al. Early Detection of Decreased Soluble HLA‐G Levels in the Maternal Cir culation Predicts the Occurrence of Preeclampsia and Intrauterine Growth Retardation During Further Course of Pregnancy. Am J Reprod Immun 2007;57(4): 277.
  • 23. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005; 193(1): 204.
  • 24. Rizzo R, Andersen AS, Lassen MR, Sørensen HC, Bergholt T, Larsen MH. Soluble Human Leukocyte Antigen‐G Isoforms in Maternal Plasma in Early and Late Pregnancy. Am J Reprod Immun 2009; 62(5): 320.
  • 25. Beneventi F, Locatelli E, De Amici M, Martinetti M, Spinillo A. Soluble HLA-G concentrations in obese women during pregnancy and in cord blood. J Reprod Immun 2017; 119: 31.
  • 26. García-Láez V, Serra V, Bellver J, Ferro J, Vidal C, De los Santos JM. Gene polymorphisms and HLA-G expression in spontaneous abortions. Medic Reproduc y Embriol Clín 2015; 2(3): 82-92.
  • 27. Bermingham J, Jenkins D, McCarthy T, O’Brien M. Genetic analysis of insulin-like growth factor II and HLA-G in preeclampsia. Biochem. Soc Trans 2000; 28: 215.
  • 28. Jahan P, Deepthi G, Komaravalli PL, Rani VU. A study on the role of HLA-G 14bp and ACE IN/DEL polymorphisms in pre-eclamptic South Indian women. Preg Hypertens: An Int J Women's Cardiovas Health 2014; 4(2): 164.
  • 29. Gonen-Gross T, Mandelboim O. HLA-G complexes are observed on the cell surface. Hum Immunol 2007;68(4): 227.
  • 30. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci 1998; 95: 4510.
  • 31. Lin A, Yan WH, Xu HH, Gan MF, Cai JF, Zhu M et al. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann Oncol 2007; 18: 1804.
  • 32. Guo ZY, Lv YG, Wang L, Shi SJ, Yang F, Zheng GX et al. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immun 2015; 293: 10–16.
  • 33. Seliger B, Schlaf G. Structure, expression and function of HLA-G in renal cell carcinoma. Semin in canc biol 2007; 17(6): 444.
  • 34. Lila N, Carpentier A, Amrein C, Daher IK, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
  • 35. Lila N, Amrein C, Guillemain R, Chevalier P, Fabiani JN, Carpentier A. Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. Journal heart and lung transp 2007;26(4): 421.
  • 36. Carosella ED, Moreau P, LeMaoult J, Rouas-Freiss, N. HLA-G: from biology to clinical benefits. Trends in immun 2008; 29(3): 125.
  • 37. Polankova K, Bandzuchova H, Zilinska Z, Chrenova S, Kuba D, Russ G. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients. Immunobiology 2015; 220: 533.
  • 38. Rafael S, Mendes-Junior CT, Lucena-Silva N, da Silva CLL, Rassi DM, Veiga-Castelli LC et al. Association of HLA-G 3' untranslated region variants with type 1 diabetes mellitus. Hum Immunol 2016; 77(4): 358
  • 39. Beneventi F, Badulli C, Locatelli E, Caporali R, Ramoni V, Cavagnoli C et al. Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases. J reprod immune 2015; 110: 67.
  • 40. Park KS, Nam JH, Lee ES, Choi JS, Bang D, Lee S. Increased risk of human leukocyte antigen-G gene variants in Behcet’s disease. Clin. Exp Rheumatol 2006; 24: 126.
  • 41. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES. HLA-E*0101 and HLAG*010101 reduce the risk of Behcet’s disease. Tissue Antigens 2007; 69: 139.
  • 42. Sakly K, Maatouk M, Hammami S, Harzallah O, Sakly W, Feki S et al. HLA-G 14bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet’s disease Tunisian patients. Hum Immunol 2016; 77(1): 90-95.
  • 43. Zhang X, Li S, Zhang Y, Lu Y, Wang J, Xu J et al. Meta-analysis of the relationship between 14bp insertion/deletion polymorphism of HLA-G gene and susceptibility to systemic lupus erythematosus. Hum Immunol 2014; 75(12): 1171.
  • 44. Zhang JB, Wang ZY, Chen J, Wu XD, Zhou B, Yie SM. The expression of human leukocyte antigen G (HLA-G) is associated with sacroiliitis stages of ankylosing spondylitis. Immunol Lett 2013;152(2): 121.
  • 45. Rajasekaran A, Shivakumar V, Kalmady SV, Narayanaswamy JC, Subbana M, Venugopal D et al. The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia. Hum Immunol 2016; 77(12): 1166.
  • 46. Fredj NB, Sakly K, Bortolotti D, Aissi M, Frih-Ayed M, Rotola, A et al. The association between functional HLA-G 14bp insertion/deletion and+ 3142 C>G polymorphisms and susceptibility to multiple sclerosis. Immunol Lett 2016; 180: 24.
  • 47. Torres MI, Lopez Casado MA, Rios A. New aspects in celiac disease. World J Gastroenterol 2007; 13: 1156.
  • 48. Fabris A, Segat L, Catamo E, Morgutti M, Vendramin A, Crovella S. HLA-G 14bp deletion/insertion polymorphism in celiac disease. Am J Gastroenterol 2011; 106: 139.
  • 49. Catamo E, Zupin L, Segat L, Celsi F, Crovella S et al. HLA-G and susceptibility to develop celiac disease. Hum Immunol 2015;76(1): 36.
  • 50. Lozano JM, Gonzalez R, Kindelan JM, Rouas-Freiss N, Caballos R. Monocytes and T lymphocytes in HIV-1- positive patients express HLA-G molecule. AIDS 2002; 16: 347.
APA GÜRBÜZ B, SOYOZ M, AYNA T, Pirim I (2020). HLA-G with Benefits and Damages: A Review. , 138 - 142. DOI: 10.5152/EurJTher.2019.18063
Chicago GÜRBÜZ Burcu CERCİ,SOYOZ Mustafa,AYNA Tülay KILIÇARSLAN,Pirim Ibrahim HLA-G with Benefits and Damages: A Review. (2020): 138 - 142. DOI: 10.5152/EurJTher.2019.18063
MLA GÜRBÜZ Burcu CERCİ,SOYOZ Mustafa,AYNA Tülay KILIÇARSLAN,Pirim Ibrahim HLA-G with Benefits and Damages: A Review. , 2020, ss.138 - 142. DOI: 10.5152/EurJTher.2019.18063
AMA GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I HLA-G with Benefits and Damages: A Review. . 2020; 138 - 142. DOI: 10.5152/EurJTher.2019.18063
Vancouver GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I HLA-G with Benefits and Damages: A Review. . 2020; 138 - 142. DOI: 10.5152/EurJTher.2019.18063
IEEE GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I "HLA-G with Benefits and Damages: A Review." , ss.138 - 142, 2020. DOI: 10.5152/EurJTher.2019.18063
ISNAD GÜRBÜZ, Burcu CERCİ vd. "HLA-G with Benefits and Damages: A Review". (2020), 138-142. https://doi.org/DOI: 10.5152/EurJTher.2019.18063
APA GÜRBÜZ B, SOYOZ M, AYNA T, Pirim I (2020). HLA-G with Benefits and Damages: A Review. European Journal of Therapeutics, 26(2), 138 - 142. DOI: 10.5152/EurJTher.2019.18063
Chicago GÜRBÜZ Burcu CERCİ,SOYOZ Mustafa,AYNA Tülay KILIÇARSLAN,Pirim Ibrahim HLA-G with Benefits and Damages: A Review. European Journal of Therapeutics 26, no.2 (2020): 138 - 142. DOI: 10.5152/EurJTher.2019.18063
MLA GÜRBÜZ Burcu CERCİ,SOYOZ Mustafa,AYNA Tülay KILIÇARSLAN,Pirim Ibrahim HLA-G with Benefits and Damages: A Review. European Journal of Therapeutics, vol.26, no.2, 2020, ss.138 - 142. DOI: 10.5152/EurJTher.2019.18063
AMA GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I HLA-G with Benefits and Damages: A Review. European Journal of Therapeutics. 2020; 26(2): 138 - 142. DOI: 10.5152/EurJTher.2019.18063
Vancouver GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I HLA-G with Benefits and Damages: A Review. European Journal of Therapeutics. 2020; 26(2): 138 - 142. DOI: 10.5152/EurJTher.2019.18063
IEEE GÜRBÜZ B,SOYOZ M,AYNA T,Pirim I "HLA-G with Benefits and Damages: A Review." European Journal of Therapeutics, 26, ss.138 - 142, 2020. DOI: 10.5152/EurJTher.2019.18063
ISNAD GÜRBÜZ, Burcu CERCİ vd. "HLA-G with Benefits and Damages: A Review". European Journal of Therapeutics 26/2 (2020), 138-142. https://doi.org/DOI: 10.5152/EurJTher.2019.18063